Lorazepam Flashcards
Generic Name:
Lorazepam
Trade Name:
Ativan
Class:
Anticonvulsant, Sedative, Anxiolytic, Benzodiazepine, short or intermediate acting
Supplied:
4mg/mL vial
Mechanism of Action:
Agent has high affinity for the gamma-amino butyric acid (GABA) benzodiazepine receptor complex without displacing GABA, (GABA is the major inhibitory neurotransmitter in the brain). It exerts tranquilizing action on the central nervous system.
Indications and Field Use
- Status epilepticus
- Seizure
- Agitation
Contraindications:
- Known sensitivity to the benzodiazepines
- Acute narrow angle glaucoma or myasthenia gravis
- Known hypersensitivity to polyethylene glycol, propylene glycol or beryl alcohol
- Pregnancy (relative)
Adverse Reactions:
- Most frequent adverse reaction is sedation
- Transient amnesia or memory impairment
- Confusion
- Hypotension
- Respiratory depression
- Dizziness
- Headache
Incompatibilities/Drug Interactions:
Concomitant use of CNS sedatives such as phenothiazines, narcotic analgesics, barbiturates, antidepressants, and alcohol should be assessed prior to administration of IV Lorazepam.
Administration:
IM: Should be administered deep into the muscle mass
IV/IO: Do not exceed 2mg/minute or 0.05mg/kg over 2-5 minutes. Dilute IV dose with equal volume of compatible dilutent (D5W, NS, SWI).
Inadvertent intra-arterial injection may produce arteriospasm resulting in necrosis and potential amputation.
Adult Dosage: Status epilepticus:
2mg to 5mg IV/IO given slowly (over 2 to 5 minutes) May repeat dose in 10 to 15 minutes if needed (maximum 10mg). May give IM if no IV/IO access.
Pediatric Dosage: Status epilepticus:
0.05 - 0.1 mg/kg IV/IO over 2 to 5 minutes (maximum 4 mg). May repeat in 10 to 15 minutes.
Routes of Administration:
- IV injection is the route of choice
- IM injections with large bore needle
- IO
Onset of Action:
1 to 2 minutes if given IV/IO
Peak Effects:
- Less than 15 minutes when given IV/IO
- Within 3 hours given IM
Duration of Action:
Approximately 6 to 8 hours
Arizona Drug Box Minimum Supply:
8mg
Special Notes:
- For age >60 or weight <60 kg: Consideration of lower doses must be made when administering Lorazepam IV to elderly patients, seriously ill patients, and those with limited pulmonary reserve. Apnea and/or cardiac arrest may occur. Patients over the age of 50 years may have a more profound and prolonged sedation with IV Lorazepam.
- All patients should be monitored for respiratory depression and hypotensive effects. Stability above room temperature has not been established.
- Be prepared to ventilate, OD may be reversed with Flumazenil, for IV/IO use, dilute 1:1 in NS.